SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Avida Global acquires Canna Creations and Green Stem CBD

    By

    Avida Global will be a fully vertically integrated seed-to-sale business thanks to its new acquisition of Canna Creations and Green Stem CBD. 

    The acquisition of Canna Creations, a full-service manufacturing and CBD potency testing business, and Green Stem CBD, Canna Creations’ own CBD brand means that Avida Global now controls the entire lifecycle of its medical cannabis oils. 

    White-labelling manufacturing business, Canna Creations, produces a wide range of CBD products for several high-street retailers, and Green Stem CBD is Canna Creation’s own brand, one of only four CBD brands currently available on Amazon, and is stocked in Boots and other high street retailers.

    Avida Global CEO, David Kirby, commented: “The acquisition of Canna Creations and Green Stem CBD to Avida Global marks a transformative milestone in our plans to create an innovative fully integrated seed-to-sales business. 

    “Both are high-quality brands in keeping with our own philosophy, and we are already building on our various synergies to create exciting opportunities globally.”

    Founder of Canna Creations, Brett Horth, and CEO of Canna Creations and Green Stem CBD, Nathan Whitman, both veterans in the cannabis industry, will assume senior leadership positions. Horth will take up the position of Avida Global CEO, Australia, New Zealand and Asia and join the Avida Global board, and Whitman will assume the position of MD of Avida Global Labs and Green Stem CBD.

    “The addition of Brett Horth and Nathan Whitman to the Avida Global team is hugely exciting. They are both dynamic cannabis and CBD veterans and a bring a wealth of experience with them and a shared desire to benefit patients, customers and shareholders,” added Kirkby.

    Canna Creations will be rebranded to Avida Global Labs whilst Green Stem CBD will retain its name.

    Horth commented: “I am incredibly excited not only for the opportunity for Green Stem CBD to be presented on the global stage as part of Avida Global, and being an intrinsic part of a fully vertical operation, but also for the new opportunities that await as CEO of Avida Global Australia, New Zealand and Asia.”

    “I am honoured to join a world-class team of cannabis experts within Avida’s Global network. Canna Creations and Green Stem CBD will benefit in the now established vertical operation which enhances our inhouse formulation and testing capabilities, bringing affordable premium products to a global market,” commented Whitman.

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free